Neuberg Diagnostics is preparing for an Initial Public Offering (IPO) in FY2028, with plans to raise up to ₹4,000 crore as the diagnostics chain accelerates its expansion across India through strategic acquisitions and infrastructure development.

As part of its pre-IPO roadmap, the Chennai based diagnostics company plans to raise around ₹500 crore in a pre IPO funding round over the next three to six months. The capital will primarily be used to acquire four to five diagnostic companies, strengthening Neuberg’s presence in key regional markets and expanding its nationwide laboratory network.

According to the company’s leadership, Neuberg expects to invest between ₹700 crore and ₹1,000 crore over the coming years through a combination of fresh capital, internal accruals and debt. The investment will support acquisitions, laboratory expansion, advanced diagnostic technologies and digital healthcare capabilities as demand for quality diagnostics continues to grow across the country.

Founded in 2017, Neuberg Diagnostics has emerged as one of India’s leading integrated diagnostics providers, operating a network of laboratories and collection centres across multiple states. The company offers a comprehensive portfolio of pathology, molecular diagnostics, genomics, preventive health screening and specialized laboratory services, serving both domestic and international markets.

India’s diagnostics sector is witnessing rapid growth, driven by rising healthcare awareness, increasing incidence of lifestyle diseases, expansion of preventive health check-ups and greater adoption of advanced diagnostic technologies. Industry estimates project that the Indian diagnostics market, currently valued at around USD 15–18 billion, is expected to grow at a compound annual growth rate (CAGR) of 10–12%, crossing USD 35 billion by 2030.

Healthcare industry experts believe consolidation within the diagnostics sector is likely to accelerate as companies seek to expand geographically, strengthen technology capabilities and improve access to specialized testing services. Strategic acquisitions are increasingly becoming a preferred route for scaling operations in a highly fragmented diagnostics market.

Neuberg’s planned IPO reflects growing investor confidence in India’s healthcare and diagnostics sector, where increasing demand for preventive healthcare, precision diagnostics and digital laboratory services continues to create long term growth opportunities. The proposed listing is expected to provide the company with additional capital to strengthen its market presence and support its next phase of expansion.